S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against PDL BioPharma, Inc.|
|SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In PDL BioPharma, Inc. To Contact Brower Piven Before The November 17, 2014 Lead Plaintiff Deadline In Class Action Lawsuit|
|SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against PDL BioPharma Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 17, 2014|
|Deadline in Lawsuit for Investors in PDL BioPharma Inc (PDLI) Shares Announced by Shareholders Foundation|
|PDL BIOPHARMA 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against PDL BioPharma, Inc. -- PDLI|
|SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PDL BioPharma, Inc. and Certain Officers - PDLI|
|SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in PDL BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadline -- PDLI|
|PDL BioPharma Announces Third Quarter 2014 and Year to Date Financial Results|
|PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million|
|PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics|
Click above to view more mutual fund data and stats for pdli - PDL BioPharma Inc.